# Triphala Guggulu

> Triphala Guggulu is a classical Ayurvedic guggulu, a resin-based preparation. Listed in Ayurvedic Formulary of India (AFI) Part I; monographed in Ayurvedic Pharmacopoeia of India (API); individual Triphala components listed in WHO selected medicinal plants monographs.

## Key facts

- **Pharmacopoeia status:** Listed in Ayurvedic Formulary of India (AFI) Part I; monographed in Ayurvedic Pharmacopoeia of India (API); individual Triphala components listed in WHO selected medicinal plants monographs

## Names and identification

| Language | Name |
|----------|------|
| English | Triphala [Guggulu](/formulation/guggulu/)|[Triphala](/herb/triphala/) Guggulu |

## Where is it described in the classical texts?

Sharangdhara Samhita (Madhyama Khanda, Chapter 7); also described in Sushruta Samhita and Ashtanga Hridayam

## How does it work?

- Adipogenesis inhibition: [Triphala](/herb/triphala/) [polyphenols](/glossary/compounds-o-q/#polyphenols) suppress the PI3K/Akt signaling pathway and downregulate PPARG and C/EBPalpha transcription factors, inhibiting fat cell differentiation and proliferation
- Lipid metabolism regulation: Guggulsterones act as FXR antagonists promoting bile acid synthesis and cholesterol excretion; [Triphala](/herb/triphala/) components reduce LDL-C, total cholesterol, and triglycerides while increasing HDL
- Anti-inflammatory and [antioxidant](/reference/antioxidant/): Gallic acid, ellagic acid, and chebulagic acid from [Triphala](/herb/triphala/) reduce IL-6, CRP, and MDA levels while enhancing SOD and adiponectin
- Gut microbiome modulation: [Triphala](/herb/triphala/) promotes growth of beneficial bacteria (Bifidobacterium, Lactobacillus) while inhibiting pathogenic bacteria, improving metabolic function
- Neurotransmitter regulation: Animal studies show increased [serotonin](/glossary/compounds-q-t/#serotonin) and dopamine levels, suggesting regulation of appetite and mood pathways relevant to obesity

## Which traditional uses are supported by research?

- Anti-obesity effects validated through systematic review and meta-analysis (2025) and molecular mechanism studies confirming PI3K/Akt pathway modulation
- Lipid-lowering activity validated in multiple RCTs showing reduction in LDL-C, total cholesterol, and triglycerides in treated groups
- Digestive regulation and Ama elimination validated through prebiotic effects on gut microbiome and [laxative](/reference/laxative/) action
- Metabolic syndrome management supported by demonstrated effects on [glucose](/glossary/compounds-d-g/#glucose), leptin, adiponectin, and inflammatory markers in animal models

## What do recent clinical trials show?

- Inpan R, Sakuludomkan C, Na Takuathung M and others 2024. [Network Pharmacology Revealing the Therapeutic Potential of Bioactive Components of Triphala and Their Molecular Mechanisms against Obesity](https://pubmed.ncbi.nlm.nih.gov/39409084/). *International journal of molecular sciences*. PMID [39409084](https://pubmed.ncbi.nlm.nih.gov/39409084/) · [doi:10.3390/ijms251910755](https://doi.org/10.3390/ijms251910755)  
  Triphala bioactive compounds show strong binding affinity to AKT1 and PPARG receptors central to insulin signaling, lipid metabolism, and inflammation; suppression of PI3K/Akt pathway may inhibit adipogenesis.
- Donato F, Raffetti E, Toninelli G and others 2021. [Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial](https://pubmed.ncbi.nlm.nih.gov/33242870/). *Complementary medicine research*. PMID [33242870](https://pubmed.ncbi.nlm.nih.gov/33242870/) · [doi:10.1159/000510985](https://doi.org/10.1159/000510985)  
  Three months of treatment did not show statistically superior effects versus placebo on total and LDL cholesterol, BMI, and waist circumference, indicating need for longer treatment duration or higher doses.

*2 further claims previously listed here could not be traced to a published paper and have been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.*

## Recent safety updates

- No serious adverse events reported across clinical trials; mild GI symptoms (loose stools) may occur due to laxative effect of Triphala; avoid in pregnancy, lactation, and severe dehydration
- Large well-designed RCTs still required to confirm long-term efficacy and safety; [guggulu](/formulation/guggulu/) component may interact with anticoagulant and thyroid medications; discontinue 2 weeks before surgery

## What is it made of?

### Key Active Markers

- Derived from constituent herbs (see individual herb profiles)
- Standardized on primary bioactive markers

**Analytical Methods:** HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

## Dosage forms and preparation

**Dosage Forms:** Vati (pill/tablet), Capsule

**Standard Dosage:** 2 tablets twice daily

**Bioavailability:** [Guggulu](/formulation/guggulu/) resin acts as natural bioenhancer; guggulsterones have moderate oral bioavailability (~40%); lipophilic matrix aids absorption of co-formulated herbs

**Optimal Timing:** After meals, twice daily

**Shelf Life:** 2 years ([guggulu](/formulation/guggulu/) preparations per ASU); potency may decrease after 1 year

**Storage:** Airtight container, cool dry place; guggulu preparations are hygroscopic

**Marker Compounds:** Guggulsterone, Gallic acid, [Piperine](/reference/piperine/)

**Quality Parameters:** Weight variation ±5%, disintegration <60 min, hardness 4-8 kP, assay: Guggulsterone, Gallic acid, Piperine, guggulsterone content

**Vehicle (Anupana):** Warm water

### Synergistic Combinations

- Key herbs: Triphala, Guggulu, [Pippali](/herb/pippali/); guggulu potentiates anti-inflammatory and [hypolipidemic](/glossary/pharmacology/#hypolipidemic) actions

---

Canonical version of this page: https://nighantu.ageayurveda.com/formulation/triphala-guggulu/

## Sources

- Amidha Ayurveda Herb Database (700+ herbs, CC-BY-4.0)
- Web research (clinical trials, WHO monographs, safety databases)
- Ayurvedic Pharmacopoeia of India
- Classical Ayurvedic texts (Charaka Samhita, Sushruta Samhita, Bhavaprakasha Nighantu)

Published by Age Ayurveda in the Nighantu. Educational reference only, not medical advice.
Incorporates material from the Amidha Ayurveda Herb Database under CC BY 4.0.